{"id":"https://openalex.org/W4400335353","doi":"https://doi.org/10.3389/fonc.2024.1371313","title":"The efficacy and safety of immunotherapy as first\u2212line treatment for extensive-stage small cell lung cancer: evaluating based on reconstructed individual patient data","display_name":"The efficacy and safety of immunotherapy as first\u2212line treatment for extensive-stage small cell lung cancer: evaluating based on reconstructed individual patient data","alternate_titles":[],"publication_year":2024,"publication_date":"2024-07-04","ids":{"openalex":"https://openalex.org/W4400335353","doi":"https://doi.org/10.3389/fonc.2024.1371313","pmid":"https://pubmed.ncbi.nlm.nih.gov/39026980","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11254656"},"language":"en","primary_location":{"id":"doi:10.3389/fonc.2024.1371313","doi":"https://doi.org/10.3389/fonc.2024.1371313","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2024.1371313","pdf_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2024.1371313/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4400335353"],"child_works_count":1,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2024.1371313/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100321563","display_name":"Shuang Zhang","orcid":"https://orcid.org/0000-0002-4339-0761","observed_orcids":["https://orcid.org/0000-0002-4339-0761"]},"institutions":[{"id":"https://openalex.org/I4210098607","display_name":"Jilin Province Tumor Hospital","ror":"https://ror.org/00vgek070","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210098607"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Shuang Zhang","raw_affiliation_strings":["Clinical Research Big Data Center, Jilin Cancer Hospital, Changchun, China","Department of Thoracic Oncology, Jilin Cancer Hospital, Changchun, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Big Data Center, Jilin Cancer Hospital, Changchun, China","institution_ids":["https://openalex.org/I4210098607"]},{"raw_affiliation_string":"Department of Thoracic Oncology, Jilin Cancer Hospital, Changchun, China","institution_ids":["https://openalex.org/I4210098607"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100415925","display_name":"Shuang Li","orcid":"https://orcid.org/0000-0002-6828-5925","observed_orcids":["https://orcid.org/0000-0002-6828-5925"]},"institutions":[{"id":"https://openalex.org/I4210098607","display_name":"Jilin Province Tumor Hospital","ror":"https://ror.org/00vgek070","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210098607"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Shuang Li","raw_affiliation_strings":["Clinical Research Big Data Center, Jilin Cancer Hospital, Changchun, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Research Big Data Center, Jilin Cancer Hospital, Changchun, China","institution_ids":["https://openalex.org/I4210098607"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112852466","display_name":"Ying Cheng","orcid":"https://orcid.org/0009-0008-8384-2647","observed_orcids":["https://orcid.org/0009-0008-8384-2647"]},"institutions":[{"id":"https://openalex.org/I4210098607","display_name":"Jilin Province Tumor Hospital","ror":"https://ror.org/00vgek070","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210098607"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Ying Cheng","raw_affiliation_strings":["Department of Thoracic Oncology, Jilin Cancer Hospital, Changchun, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Thoracic Oncology, Jilin Cancer Hospital, Changchun, China","institution_ids":["https://openalex.org/I4210098607"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5112852466"],"corresponding_institution_ids":["https://openalex.org/I4210098607"],"apc_list":{"value":3295,"currency":"USD","value_usd":3295},"apc_paid":{"value":3295,"currency":"USD","value_usd":3295},"fwci":0.2394,"has_fulltext":true,"cited_by_count":5,"citation_normalized_percentile":{"value":0.25023552,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":97},"biblio":{"volume":"14","issue":null,"first_page":"1371313","last_page":"1371313"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0034000000450760126,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/extensive-stage-small-cell-lung-cancer","display_name":"extensive-stage small cell lung cancer","score":0.9929999709129333},{"id":"https://openalex.org/keywords/first-line-immunotherapy","display_name":"first-line immunotherapy","score":0.8149999976158142},{"id":"https://openalex.org/keywords/pd-l1-inhibitors","display_name":"PD-L1 inhibitors","score":0.9100000262260437},{"id":"https://openalex.org/keywords/pd-1-inhibitors","display_name":"PD-1 inhibitors","score":0.9980000257492065},{"id":"https://openalex.org/keywords/anlotinib","display_name":"anlotinib","score":0.902999997138977},{"id":"https://openalex.org/keywords/tiragolumab","display_name":"tiragolumab","score":0.9850000143051147},{"id":"https://openalex.org/keywords/tremelimumab","display_name":"tremelimumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9200000166893005},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":1.0},{"id":"https://openalex.org/keywords/restricted-mean-survival-time","display_name":"restricted mean survival time","score":0.7540000081062317},{"id":"https://openalex.org/keywords/indirect-comparison","display_name":"indirect comparison","score":0.5080000162124634},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.39500001072883606},{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.5789999961853027},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitor-related-pneumonitis","display_name":"immune-related pneumonitis","score":0.4909999966621399}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7600439786911011},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.7509597539901733},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.712642252445221},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6374432444572449},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.6249723434448242},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5721116662025452},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.46038082242012024},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.44383466243743896},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.4336303472518921},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.42970070242881775},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.33875933289527893}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fonc.2024.1371313","doi":"https://doi.org/10.3389/fonc.2024.1371313","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2024.1371313","pdf_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2024.1371313/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11254656","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11254656","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11254656/pdf/fonc-14-1371313.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Oncol","raw_type":"Text"},{"id":"pmid:39026980","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39026980","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in oncology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:839307f389b04aab8bfa77367bc15984","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/839307f389b04aab8bfa77367bc15984","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Oncology, Vol 14 (2024)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fonc.2024.1371313","doi":"https://doi.org/10.3389/fonc.2024.1371313","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fonc.2024.1371313","pdf_url":"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2024.1371313/pdf","source":{"id":"https://openalex.org/S2596394214","display_name":"Frontiers in Oncology","issn_l":"2234-943X","issn":["2234-943X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"},{"id":"https://openalex.org/study-designs/meta-analysis","display_name":"Meta-Analysis"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320322174","display_name":"People's Government of Jilin Province","ror":"https://ror.org/02fzqav45"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4400335353.pdf","grobid_xml":"https://content.openalex.org/works/W4400335353.grobid-xml"},"referenced_works_count":42,"referenced_works":["https://openalex.org/W1884032213","https://openalex.org/W1991235944","https://openalex.org/W2050118439","https://openalex.org/W2056631765","https://openalex.org/W2107752337","https://openalex.org/W2118471749","https://openalex.org/W2120959053","https://openalex.org/W2145857936","https://openalex.org/W2150683078","https://openalex.org/W2151981428","https://openalex.org/W2260064945","https://openalex.org/W2266436416","https://openalex.org/W2268710619","https://openalex.org/W2275034928","https://openalex.org/W2411674742","https://openalex.org/W2617476695","https://openalex.org/W2765782352","https://openalex.org/W2791551980","https://openalex.org/W2893960509","https://openalex.org/W2942617524","https://openalex.org/W2956519428","https://openalex.org/W2977392388","https://openalex.org/W3011497962","https://openalex.org/W3030178583","https://openalex.org/W3107468528","https://openalex.org/W3110002524","https://openalex.org/W3118711697","https://openalex.org/W3163923489","https://openalex.org/W3183217190","https://openalex.org/W3185141887","https://openalex.org/W3192405706","https://openalex.org/W4280546819","https://openalex.org/W4289544355","https://openalex.org/W4297251744","https://openalex.org/W4319224783","https://openalex.org/W4323362598","https://openalex.org/W4360604374","https://openalex.org/W4382023395","https://openalex.org/W4387809573","https://openalex.org/W4388075489","https://openalex.org/W4388753162","https://openalex.org/W4392554447"],"related_works":["https://openalex.org/W4390938691","https://openalex.org/W4389419951","https://openalex.org/W4385751375","https://openalex.org/W7162637738","https://openalex.org/W4313330164","https://openalex.org/W4311514595","https://openalex.org/W4414053801","https://openalex.org/W3092751291","https://openalex.org/W4401099482","https://openalex.org/W3085646757"],"abstract_inverted_index":{"Objective:":[0],"Selecting":[1],"between":[2,252,343],"programmed":[3,11],"cell":[4,12,25],"death":[5,13],"ligand":[6],"1":[7,14],"(PD-L1)":[8],"inhibitor":[9,16,111,118,127,179],"or":[10],"(PD-1)":[15],"plus":[17,112,119,130,356,364,375],"chemotherapy":[18,113,120,129,357,365,376],"as":[19,48,366],"first-line":[20,49,367],"treatment":[21,50,368],"for":[22,160,240,282],"extensive-stage":[23],"small":[24],"lung":[26],"cancer":[27],"(ES-SCLC)":[28],"patients":[29,53],"urgently":[30],"needs":[31],"to":[32,70,285,295,327,361],"be":[33],"answered.":[34],"Methods:":[35],"Eligible":[36],"phase":[37],"3":[38,314],"randomized":[39],"clinical":[40],"trials":[41],"evaluating":[42],"regimens":[43],"based":[44],"on":[45,57],"PD-1/PD-L1":[46],"inhibitors":[47,355,363,374],"in":[51,218,322,369],"ES-SCLC":[52,370],"were":[54,77,103,167,213],"systematically":[55],"searched":[56],"the":[58,80,84,93,97,109,140,147,157,161,168,173,177,187,197,253,257,262,286,296,300,307,323,328,337,344],"PubMed":[59],"and":[60,64,88,124,128,136,170,176,186,189,200,235,237,245,256,280],"Cochrane":[61],"Library":[62],"databases":[63],"major":[65],"international":[66],"conferences":[67],"from":[68,79],"01/01/2018":[69],"18/09/2023.":[71],"The":[72,100,164,181,289,310],"individual":[73],"patient":[74],"data":[75,102],"(IPD)":[76],"recuperated":[78],"Kaplan-Meier":[81],"curves":[82],"of":[83,92,172,196,206,312,339],"overall":[85],"survival":[86,90,193],"(OS)":[87],"progression-free":[89],"(PFS)":[91],"included":[94,184],"studies":[95,208],"using":[96,156],"IPDfromKM":[98],"method.":[99],"reconstructed":[101,349],"pooled":[104],"into":[105],"unified":[106],"arms,":[107],"including":[108,209],"PD-L1":[110,141,174,198,254,287,297,308,329,362,373],"group":[114,121,142,175,199,255,264,291,302,325,330],"(PD-L1":[115],"group),":[116,123],"PD-1":[117,125,178,201,258,324,354],"(PD-1":[122],"(L1)":[126],"other":[131,148],"(anlotinib":[132],"group,":[133,135],"tiragolumab":[134,290],"tremelimumab":[137,301],"group).":[138],"Subsequently,":[139],"was":[143,154,250,319,341],"indirectly":[144],"compared":[145,284,326],"with":[146],"groups.":[149,346],"A":[150,204],"standard":[151],"statistical":[152],"analysis":[153,351],"conducted":[155],"\"survival\"":[158],"package":[159],"time-to-event":[162],"endpoint.":[163],"primary":[165],"outcomes":[166,183],"OS":[169,229,241,268,283],"PFS":[171,219,274],"group.":[180,202,259,288,298,309],"secondary":[182],"safety":[185,380],"12-":[188],"24-month":[190,238],"restricted":[191],"mean":[192],"time":[194],"(RMST)":[195],"Results:":[203],"total":[205],"9":[207],"11":[210],"immunotherapy":[211],"cohorts":[212],"included.":[214],"No":[215],"significant":[216],"difference":[217],"(hazard":[220],"ratio":[221],"[HR]:":[222],"0.96,":[223],"95%":[224,232,271,277],"confidence":[225],"interval":[226],"[CI]:":[227],"0.86-1.06),":[228],"(HR:":[230,269,275],"0.94,":[231],"CI:":[233,272,278],"0.84-1.05),":[234],"12-month":[236],"RMST":[239,281],"(P":[242],"=":[243,247],"0.198":[244],"P":[246,334],"0.216,":[248],"respectively)":[249],"observed":[251],"In":[260],"contrast,":[261],"anlotinib":[263],"showed":[265,292],"significantly":[266,320],"better":[267,379],"0.70,":[270],"0.55-0.89),":[273],"0.69,":[276],"0.58-0.83),":[279],"similar":[293,342,359],"efficacy":[294,305,360],"However,":[299],"exhibited":[303],"inferior":[304],"than":[306],"incidence":[311,338],"\u2265grade":[313],"treatment-emergent":[315],"adverse":[316],"events":[317],"(TEAEs)":[318],"higher":[321],"(85.4%":[331],"vs.":[332],"69.6%,":[333],"<.001),":[335],"whereas":[336,372],"irAEs":[340],"two":[345],"Conclusion:":[347],"This":[348],"IPD":[350],"revealed":[352],"that":[353],"achieved":[358],"patients,":[371],"had":[377],"a":[378],"profile.":[381]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4400335353","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":2}],"updated_date":"2026-11-15T12:55:33.944570","created_date":"2024-07-06T00:00:00"}
